XML 35 R24.htm IDEA: XBRL DOCUMENT v3.19.1
Share based Compensation (Tables)
3 Months Ended
Mar. 31, 2019
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of Fair Value of Options
The fair value of the stock options granted is estimated on the date of grant using a Black-Scholes option pricing model with the following weighted-average assumptions:
 
 
Three Months Ended March 31,
 
2019
 
2018
Expected stock price volatility
74.2
%
 
81.2
%
Risk free interest rate
2.5
%
 
2.3
%
Expected life of options (years)
5.68

 
5.67

Expected annual dividend per share
$

 
$

Schedule of Stock Options Activity
A summary of the Company's stock options for the three months ended March 31, 2019 were as follows:
 
 
Number of
Shares
 
Weighted
Average
Exercise Price
 
Weighted
Average
Remaining
Contractual Life
 
Aggregate
Intrinsic
Value
 
(in thousands)
 
 
 
 
 
(in millions)
Options outstanding, December 31, 2018
15,810

 
$
8.63

 
 
 
 

Granted
3,315

 
$
10.15

 
 
 
 

Exercised
(578
)
 
$
6.83

 
 
 
 

Forfeited
(195
)
 
$
10.33

 
 
 
 

Expired
(21
)
 
$
10.77

 
 
 
 
Options outstanding, March 31, 2019
18,331

 
$
8.94

 
6.9 years
 
$
90.2

Vested and unvested expected to vest, March 31, 2019
17,325

 
$
8.84

 
6.8 years
 
$
87.1

Exercisable at March 31, 2019
10,538

 
$
7.84

 
5.5 years
 
$
62.8

Schedule of Non-Vested RSU Activity under the Plan
A summary of non-vested RSU activity under the Plan for the three months ended March 31, 2019 is as follows:
 
 
Number of Shares

 
Weighted
Average Grant Date
Fair Value
 
Weighted Average
Remaining Years
 
Aggregate Intrinsic
Value 
 
(in thousands)
 
 
 
 
 
(in millions)
Non-vested units as of December 31, 2018
3,712

 
$
10.59

 
 
 
 

Granted
3,031

 
$
10.91

 
 
 
 

Vested
(600
)
 
$
9.07

 
 
 
 

Forfeited
(133
)
 
$
12.73

 
 
 
 

Non-vested units as of March 31, 2019
6,010

 
$
10.86

 
3.0 years
 
$
81.7

Schedule of Equity Compensation Expenses
The following table summarizes information related to compensation expense recognized in the statements of operations related to the equity awards:
 
 
Three Months Ended March 31,
(in thousands)
 
2019
 
2018
Equity compensation expense recognized in:
 
 

 
 

Research and development expense
 
$
5,032

 
$
3,057

Selling, general and administrative expense
 
7,712

 
4,421

Total equity compensation expense
 
$
12,744

 
$
7,478